[1]汪明. 家畜寄生虫学. 北京: 中国农业出版社, 2005: 341-342.Wang M. Veterinary Parasitology. Beijing: Agricultural Press, 2005: 341-342. (in Chinese)[2]Wang Q, Zhang S, Luo X, Hou J, Zhu X, Cai X. Cloning and characterization of a cathepsin L-like cysteine protease from Taenia pisiformis. Veterinary Parasitology, 2013 194(1): 26-34.[3]杨世广, 汪志楷, 施宝坤. 豆状带绦虫的人工感染及其发育史. 中国兽医科技, 1986, 16(6): 16-19.Yang S G, Wang Z K, Shi B K. Experimental infection of Taenia pisiformis and its life cycle. Chinese Journal of Veterinary Science and Technology, 1986, 16(6): 16-19. ( in Chinese)[4]周永学, 杜爱芳, 张雪娟, 吴文育. 我国兔豆状囊尾蚴病的研究进展. 中国养兔杂志, 2006(1): 25-28. Zhou Y X, Du A F, Zhang X J, Wu W Y. Research progress on cysticercosis pisiformis in China. Chinese Journal of Rabbit Farming, 2006(1): 25-28.(in Chinese)[5]孙晓林, 骆学农, 王晓霞, 才学鹏. 兔豆状囊尾蚴和豆状带绦虫头节的组织结构观察. 中国兽医科学, 2008, 38(09):796-800.Sun X L, Luo X N, Wang X X , Cai X P. Observation of the organizational structure of Cysticercus pisiformis andTaenia pisiformis scolex. Chinese Veterinary Science, 2008, 38(09):796-800.(in Chinese)[6]Gemmell M. Immunological responses of the mammalian host against tapeworm infections. species specificity of hexacanth embryos in protecting rabbits against Taenia Pisiformis. Immunology, 1965, 8:270-280. [7]Lightowlers M W, Rolfe R, Gauci C G. Taenia saginata: vaccination against cysticercosis in cattle with recombinant oncosphere antigens. Experimental Parasitology, 1996, 84(3): 330-338. [8]González L M, Ramiro R, García L, Parkhouse R M, McManus D P, Gárate T. Genetic variability of the 18 kDa/HP6 protective antigen in Taenia saginata and Taenia asiatica: implications for vaccine development. Molecular and Biochemical Parasitology, 2011, 176(2): 131-134. [9]Gauci C G, Flisser A, Lightowlers M W. A Taenia solium oncosphere protein homologous to host-protective Taenia ovis and Taenia saginata 18kD antigens. International Journal for Parasitology, 1998, 28(5): 757-760.[10]Cai X, Yuan G, Zheng Y, Luo X, Zhang S, Ding J, Jing Z, Lu C. Effective production and purification of the glycosylated TSOL18 antigen, which is protective against pig cysticercosis. Infection and Immunity, 2008, 76(2): 767-770.[11]Gauci C, Vural G, Oncel T, Varcasia A, Damian V, Kyngdon C T, Craig P S, Anderson G A, Lightowlers M W. Vaccination with recombinant oncosphere antigens reduces the susceptibility of sheep to infection with Taenia multiceps. International Journal for Parasitology, 2008, 38(8/9): 1041-1050.[12]Vareasia A, Tosciri G, Coccone G N, Pipia A P, Garippa G, Scala A, Damien V, Vural G, Gauci C G, Lightowlers M W. Preliminary field trial of a vaccine against coenurosis caused by Taenia multiceps. Veterinary Parasitology, 2009, 162(3/4): 285-289.[13]Hein W R, Harrison G B L. Vaccines against veterinary helminthes. Veterinary Parasitology, 2005, 132: 217-222.[14]Karimi Z, Babashamsi M, Asgarani E, Salimi A. Development of an immunoaffinity method for purification of streptokinase. Avicenna Journal of Medical Biotechnolog,2012 4(3):142-147.[15]Li T, Ito A, Chen X, Sako Y, Qiu J, Xiao N, Qiu D, Nakao M, Yanagida T, Craig P S. Specific IgG responses to recombinant antigen B and Em 18 in cystic and alveolar Echinococcosis in China. Clinical Vaccine Immunology, 2010, 17(3): 470-475.[16]Ito A, Sako Y, Yamasaki H, Mamuti W, Nakaya K, Nakao M, Ishikawa Y. Development of Em 18-immunoblot andEml8-ELISA for specific diagnosis of alveolar echinococcosis. Acta Trop, 2003,85(2): 173-182.[17]Ding J, Zheng Y, Wang Y, Dou Y, Chen X, Zhu X, Wang S, Zhang S, Liu Z, Hou J, Zhai J, Yan H, Luo X, Cai X. Immune responses to a recombinant attenuated Salmonella typhimurium strain expressing a Taenia solium oncosphere antigen TSOL18. Comparative Immunology, Microbiology and Infectious Diseases, 2013, 36: 17-23.[18]Benitez L, Garate T,Harrison LJ, Kirkham P, Brookes S M, Parkhouse R M. Cloning and sequencing of the gene encoding the principal 18-kDa secreted antigen of activated oncospheres of Taenia saginata. Molecular Biochemcal Patasitology, 1996, 78(1/2): 265-268.[19]Gauci C G, Lightowlers M W. Developmental regulation of Taenia ovis 45W gene expression. Molecular and Biochemical Parasitology, 1995, 73: 263-266.[20]Alvarez J I, Rivera J, Teale J M. Differential release and phagocytosis of tegument glycoconjugates in neurocysticercosis: Implications for immune evasion strategies. PLoS Neglected Tropical Disease, 2008, 2(4): e218.[21]蔡春, 易新元, 曾宪芳, 周金春, 舒新华, Reynolds L M C. 两种佐剂对日本血吸虫重组抗原SjGST-Sj32保护效果的影响. 中国人兽共患病杂志, 2000,16(2):46-49.Cai C, Yi X Y, Zeng X F, Zhou J C, Shu X H, Reynolds L M C. Significant protection against Schistosoma Japonicum induced by recombinant fusion protein SJGST-SJ32 with FCA or MPL. Chinese Journal of Zoonoses, 2000, 16(2):46-49. (in Chinese)[22]沈克飞, 曹兰, 尹继刚, 姜宁, 陈启军.免疫佐剂研究进展.动物医学进展, 2007, 28(增):34-36.Shen K F,Cao L,Yin J G, Jiang N, Chen Q J. Progress in adjuvants. Progress in Veterinary Medicine, 2007, 28(Suppl.):34-36. (in Chinese) [23]邓苏宏, 刘君杰, 胡四海. 细胞因子佐剂对核酸疫苗免疫效果的影响及作用机制. 细胞与分子免疫学杂志, 2013(9): 1004-1007.Deng S H, Liu J J, Hu S H. Cytokine effects on DNA vaccine adjuvant effect and mechanism of action. Chinese Journal of Cellular and Molecular Immunology, 2013(9): 1004-1007. (in Chinese) |